bladder package:survival R Documentation _B_l_a_d_d_e_r _C_a_n_c_e_r _R_e_c_u_r_r_e_n_c_e_s _D_e_s_c_r_i_p_t_i_o_n: Data on recurrences of bladder cancer, used by many people to demonstrate methodology for recurrent event modelling. Bladder1 is the full data set from the study. It contains all three treatment arms and all recurrences for 118 subjects; the maximum observed number of recurrences is 9. Bladder is the data set that appears most commonly in the literature. It uses only the 85 subjects with nonzero follow-up who were assigned to either thiotepa or placebo. The status variable is 1 for recurrence and 0 for everything else (including death for any reason). The data set is laid out in the competing risks format of the paper by Wei, Lin, and Weissfeld. Bladder2 uses the same subset of subjects as bladder, but formated in the (start, stop] or Anderson-Gill style. Note that in transforming from the WLW to the AG style data set there is a quite common programming mistake that leads to extra follow-up time for 12 subjects (all those with more than 4 recurrences); this includes some earlier releases of the data in R. _U_s_a_g_e: bladder1 bladder bladder2 _F_o_r_m_a_t: bladder1 id: Patient id treatment: Placebo, pyridoxine (vitamin B6), or thiotepa number: Initial number of tumours (8=8 or more) size: Size (cm) of largest initial tumour recur: Number of recurrences start,stop: The start and end time of each time interval status: End of interval code, 0=censored, 1=recurrence, 2=death from bladder disease, 3=death other/unknown cause rtumor: Number of tumors found at the time of a recurrence rsize: Size of largest tumor at a recurrence enum: Event number (observation number within patient) bladder id: Patient id rx: Treatment 1=placebo 2=thiotepa number: Initial number of tumours (8=8 or more) size: size (cm) of largest initial tumour stop: recurrence or censoring time enum: which recurrence (up to 4) bladder2 id: Patient id rx: Treatment 1=placebo 2=thiotepa number: Initial number of tumours (8=8 or more) size: size (cm) of largest initial tumour start: start of interval (0 or previous recurrence time) stop: recurrence or censoring time enum: which recurrence (up to 4) _S_o_u_r_c_e: Andrews DF, Hertzberg AM (1985), DATA: A Collection of Problems from Many Fields for the Student and Research Worker, New York: Springer-Verlag. LJ Wei, DY Lin, L Weissfeld (1989), Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. _Journal of the American Statistical Association_, *84*.